In colonoscopy patients, adverse reaction incidence with 2LPEG plus linaclotide was compatible with 2LPEG alone.
In plain wordsIn colonoscopy patients, adverse reaction rates were similar with 2LPEG plus linaclotide and 2LPEG alone.
- Peptide
- Linaclotide
- Outcome
- Direction not reportedAdverse reactions
- Study
n: not reported in source
- Comparator
- 2LPEG alone
- Analysis
- Secondary
- Outcome group
- Adverse events · Gastrointestinal
- Studied dose
- Dose not stated
Source sentences
Patient's sleeping quality and the incidence of adverse reactions of 2LPEG + L group were compatible with 2LPEG group, but it was significantly lower than that in 4LPEG group.
1 context sentence(design, population, supporting numbers)
A total of 266 patients who underwent colonoscopy in Shangrao People's Hospital from June 2021 to June 2022 were randomized to 1 of 3 split PEG regimens: 4LPEG, 2LPEG, and 2LPEG + L (linaclotide).